GLP-1 peptides serve as essential controls for evaluating multi-receptor compounds like Retatrutide, enabling researchers to isolate specific GLP-1-mediated effects and establish baseline expectations for receptor activation patterns
Key Properties Of The CJC-1295 And Ipamorelin Blend This table helps illustrate why these two peptides are so complementary in research applications
Young: Exactly
Approximately 180 eligible participants will be randomized in a ratio of 1:1, to receive either remibrutinib or matching placebo
Supplies Needed Plan is based on an 816 week 5x per week protocol taking the standard dose 10mg Blend Vial (5mg CJC-1295 + 5mg Ipamorelin) 8 weeks 2 vials 12 weeks 3 vials 16 weeks 4 vials Insulin Syringes 8/week total 8 weeks 40 12 weeks 60 16 weeks 80 Bacteriostatic Water 8 weeks: ~6 mL (1 bottle) 12 weeks: ~9 mL (1 bottle) 16 weeks: ~12 mL (2 bottles) Alcohol Swabs 8 weeks ~40 12 weeks ~60 16 weeks ~80 Protocol Overview Goal: Support natural growth hormone release and improve recovery, body composition, and metabolic health Schedule: Daily injections for 812 weeks (extendable to 16 weeks) Dose Range: 500 mcg (250 mcg of each peptide) 5x per week Reconstitution: 2.0 mL per vial Storage: Refrigerated after mixing
Explore our full catalog of antibodies targeting the glucagon receptor family, including tools for GLP-1R, Glucagon Receptor (GCGR), and related metabolic receptors.